This website contains promotional content and is intended for Healthcare Professionals based in the United Kingdom only. Some content is only relevant to HCPs practising in Great Britain (England, Scotland, Wales). This website is optimised for desktop use, and some features may perform differently on mobile devices.

Adverse event reporting can be found at the bottom of the page.

Praluent logo

Pharmacological properties

Figure © Sanofi.


Find more information on Indication, Administration and Mechanism of Action and watch videos about Praluent®.

Patient Website

Find resources and support for your patients on Praluent®. Find useful links about how patients can manage their cholesterol.

Get in touch with the Dyslipidaemia Team
  1. Praluent Summary of Product Characteristics. Available at Accessed October 2023.
  2. Kuhnast S, et al. J Lipid Res 2014;55:2103–2112.

MAT-XU-2204595 (v3.0) Date of Preparation: October 2023